SIC 5122 – Drugs, Drug Proprietaries, and Druggists' Sundries
| Valuation | |
|---|---|
| Market Cap ($M) | 2,082.02 |
| Enterprise Value ($M) | n/a |
| Book Value ($M) | 407,419.00 |
| Book Value / Share | 5,653.32 |
| Price / Book | n/a |
| NCAV ($M) | 137,687.00 |
| NCAV / Share | 1,910.54 |
| Price / NCAV | n/a |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.08 |
| Return on Assets (ROA) | 0.03 |
| Return on Equity (ROE) | 0.08 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.02 |
| Current Ratio | 1.24 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 844,099.00 |
| Assets | 1,113,831.00 |
| Liabilities | 706,412.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,399,952.00 |
| Operating Income | 37,126.00 |
| Net Income | 34,496.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| STEK – Stemtech Corporation | STRRF – Canadian Gold Corp. |
| SUTI – SUTIMCo International, Inc. | THCBF – THC Biomed Intl Ltd. |
| UBQU – Ubiquitech Software Corp. |
Financial data and stock pages provided by
Fintel.io